ArticleFrontiers in microbiology2017
The Validation and Implications of Using Whole Genome Sequencing as a Replacement for Traditional Serotyping for a National
Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 86 citations in OpenAlex.
- A Simplified Guide to Whole-Genome Sequence Analysis of Salmonella on the Command Line.Methods in molecular biology (Clifton, N.J.) · 2027Article
- Broiler litter moisture and trace metals contribute to the persistence ofApplied and environmental microbiology · 2025Article
- Whole genome sequencing as a reliable alternative forFrontiers in microbiology · 2025Article
- The integrated genomic surveillance system of Andalusia (SIEGA) provides a One Health regional resource connected with the clinic.Scientific reports · 2024Article
- Genomic Surveillance ofAntibiotics (Basel, Switzerland) · 2023Article
- Comparing Multiple Locus Variable-Number Tandem Repeat Analyses with Whole-Genome Sequencing as Typing Method for Salmonella Enteritidis Surveillance in The Netherlands, January 2019 to March 2020.Microbiology spectrum · 2022Article
- Mobility of antimicrobial resistance across serovars and disease presentations in non-typhoidalMicrobial genomics · 2022Article
- Molecular Characterization ofMicroorganisms · 2022Article
- Phenotypic and genotypic characterization of antimicrobial resistance profiles inFrontiers in microbiology · 2022Article
- Genomic Epidemiology of Multidrug-Resistant Nontyphoidal Salmonella in Young Children Hospitalized for Gastroenteritis.Microbiology spectrum · 2021Article
- Comparison of Molecular and In SilicoMicroorganisms · 2021Article
- Classification ofMicroorganisms · 2021Article
- Validation strategy of a bioinformatics whole genome sequencing workflow for Shiga toxin-producingMicrobial genomics · 2021Article
- Monitoring the Microevolution ofFrontiers in microbiology · 2021Article
- Rapid Real-Time Polymerase Chain Reaction forFrontiers in microbiology · 2021Article
- Molecular Epidemiology of Salmonellosis in Florida, USA, 2017-2018.Frontiers in medicine · 2021Article
- Evaluation ofFrontiers in microbiology · 2021Article
- Laboratory response checklist for infectious disease outbreaks-preparedness and response considerations for emerging threats.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2020Article
- Reply to Li et al., "GC Content-Associated Sequencing Bias Caused by Library Preparation Method May Infrequently AffectApplied and environmental microbiology · 2020Article
- Performance and Accuracy of Four Open-Source Tools forApplied and environmental microbiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.